• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/12/21 10:30:14 AM ET
    $TVTY
    Medical Specialities
    Health Care
    Get the next $TVTY alert in real time by email
    SC 13G 1 TIVITY_FINAL.txt TIVITY 13G FINAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* TIVITY HEALTH, INC. ------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.001 per share ------------------------------------------------------------------------------- (Title of Class of Securities) 88870R102 -------------------------------------------- (CUSIP Number) December 31, 2020 ------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [] Rule 13d-1(c) [] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 11 ----------------------- CUSIP No. 88870R102 13G ----------------------- ------------------------------------------------------------------------------ 1. Name of Reporting Person I.R.S. Identification No. of above Person THE GOLDMAN SACHS GROUP, INC. ------------------------------------------------------------------------------ 2. Check the Appropriate Box if a Member of a Group (a) [_] (b) [_] ------------------------------------------------------------------------------ 3. SEC Use Only ------------------------------------------------------------------------------ 4. Citizenship or Place of Organization Delaware ------------------------------------------------------------------------------ 5. Sole Voting Power Number of 0 Shares ---------------------------------------------------------- 6. Shared Voting Power Beneficially 3,652,281 Owned by ---------------------------------------------------------- Each 7. Sole Dispositive Power Reporting 0 Person ---------------------------------------------------------- 8. Shared Dispositive Power With: 3,652,286 ------------------------------------------------------------------------------ 9. Aggregate Amount Beneficially Owned by Each Reporting Person 3,652,286 ------------------------------------------------------------------------------ 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares [_] ------------------------------------------------------------------------------ 11. Percent of Class Represented by Amount in Row (9) 7.5 % ------------------------------------------------------------------------------ 12. Type of Reporting Person HC-CO ------------------------------------------------------------------------------ Page 2 of 11 ----------------------- CUSIP No. 88870R102 13G ----------------------- ------------------------------------------------------------------------------ 1. Name of Reporting Person I.R.S. Identification No. of above Person GOLDMAN SACHS & CO. LLC ------------------------------------------------------------------------------ 2. Check the Appropriate Box if a Member of a Group (a) [_] (b) [_] ------------------------------------------------------------------------------ 3. SEC Use Only ------------------------------------------------------------------------------ 4. Citizenship or Place of Organization New York ------------------------------------------------------------------------------ 5. Sole Voting Power Number of 0 Shares ---------------------------------------------------------- 6. Shared Voting Power Beneficially 3,652,281 Owned by ---------------------------------------------------------- Each 7. Sole Dispositive Power Reporting 0 Person ---------------------------------------------------------- 8. Shared Dispositive Power With: 3,652,286 ------------------------------------------------------------------------------ 9. Aggregate Amount Beneficially Owned by Each Reporting Person 3,652,286 ------------------------------------------------------------------------------ 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares [_] ------------------------------------------------------------------------------ 11. Percent of Class Represented by Amount in Row (9) 7.5 % ------------------------------------------------------------------------------ 12. Type of Reporting Person BD-OO-IA ------------------------------------------------------------------------------ Page 3 of 11 Item 1(a). Name of Issuer: TIVITY HEALTH, INC. Item 1(b). Address of Issuer's Principal Executive Offices: 701 COOL SPRINGS BOULEVARD FRANKLIN, TN 37067 Item 2(a). Name of Persons Filing: THE GOLDMAN SACHS GROUP, INC. GOLDMAN SACHS & CO. LLC Item 2(b). Address of Principal Business Office or, if none, Residence: The Goldman Sachs Group, Inc. 200 West Street New York, NY 10282 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 Item 2(c). Citizenship: THE GOLDMAN SACHS GROUP, INC. - Delaware GOLDMAN SACHS & CO. LLC - New York Item 2(d). Title of Class of Securities: Common Stock, par value $0.001 per share Item 2(e). CUSIP Number: 88870R102 Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: (a).[X] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). Goldman Sachs & Co. LLC (b).[_] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c).[_] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d).[_] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e).[X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); Goldman Sachs & Co. LLC (f).[_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g).[X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); The Goldman Sachs Group, Inc. (h).[_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i).[_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j).[_] A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k).[_] A group, in accordance with Rule 13d-1(b)(1)(ii) (A) through (K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: Page 4 of 11 Item 4. Ownership.* (a). Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s). (b). Percent of Class: See the response(s)to Item 11 on the attached cover page(s). (c). Number of shares as to which such person has: (i). Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s). (ii). Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s). (iii). Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s). (iv). Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s). Item 5. Ownership of Five Percent or Less of a Class. Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person. Clients of the Reporting Person(s) have or may have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities held in their accounts. Clients known to have such right or power with respect to more than 5% of the class of securities to which this report relates are: Account ID 749046470 owns more than 5% Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. See Exhibit (99.2) Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Section 240.14a-11. -------------------------- *In accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned by certain operating units (collectively, the "Goldman Sachs Reporting Units") of The Goldman Sachs Group, Inc. and its subsidiaries and affiliates (collectively, "GSG"). This filing does not reflect securities, if any, beneficially owned by any operating units of GSG whose ownership of securities is disaggregated from that of the Goldman Sachs Reporting Units in accordance with the Release. The Goldman Sachs Reporting Units disclaim beneficial ownership of the securities beneficially owned by (i) any client accounts with respect to which the Goldman Sachs Reporting Units or their employees have voting or investment discretion or both, or with respect to which there are limits on their voting or investment authority or both and (ii) certain investment entities of which the Goldman Sachs Reporting Units act as the general partner, managing general partner or other manager, to the extent interests in such entities are held by persons other than the Goldman Sachs Reporting Units. Page 5 of 11 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 10, 2021, THE GOLDMAN SACHS GROUP, INC. By:/s/ Nicole Clark ---------------------------------------- Name: Nicole Clark Title: Attorney-in-fact GOLDMAN SACHS & CO. LLC By:/s/ Nicole Clark ---------------------------------------- Name: Nicole Clark Title: Attorney-in-fact Page 6 of 11 INDEX TO EXHIBITS Exhibit No. Exhibit ----------- ------- 99.1 Joint Filing Agreement 99.2 Item 7 Information 99.3 Power of Attorney, relating to THE GOLDMAN SACHS GROUP, INC. 99.4 Power of Attorney, relating to GOLDMAN SACHS & CO. LLC Page 7 of 11 EXHIBIT (99.1) JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, par value $0.001 per share, of TIVITY HEALTH, INC. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G. Date: February 10, 2021, THE GOLDMAN SACHS GROUP, INC. By:/s/ Nicole Clark ---------------------------------------- Name: Nicole Clark Title: Attorney-in-fact GOLDMAN SACHS & CO. LLC By:/s/ Nicole Clark ---------------------------------------- Name: Nicole Clark Title: Attorney-in-fact Page 8 of 11 EXHIBIT (99.2) ITEM 7 INFORMATION The securities being reported on by The Goldman Sachs Group, Inc. ("GS Group"), as a parent holding company, are owned, or may be deemed to be beneficially owned, by Goldman Sachs & Co.LLC ("Goldman Sachs"),a broker or dealer registered under Section 15 of the Act and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940. Goldman Sachs is a subsidiary of GS Group. Page 9 of 11 EXHIBIT (99.3) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS THE GOLDMAN SACHS GROUP, INC.(the "Company") does hereby make,constitute and appoint each of Stephanie Snyder, Jerry Li, Nicole Clark, Jamie Minieri, Terry Mosher, Rachel Fraizer, and Terrance Grey acting individually, its true and lawful attorney, to execute and deliver in its name and on its behalf whether the Company is acting individually or as representative of others, any and all filings required to be made by the Company pursuent to Rule 13f-1 or Regulation 13D-G under the Securities Exchange Act of 1934, (as amended, the "Act"), which may be required of the Company with respect to securities which may be deemed to be beneficially owned by the Company under the Act, giving and granting unto each said attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said Attorney-in-fact shall lawfully do or cause to be done by virtue hereof. THIS POWER OF ATTORNEY shall remain in full force and effect until March 1, 2022 unless earlier revoked by written instrument, or in the event an Attorney-in-fact ceases to be an employee of The Goldman Sachs Group, Inc. or one of its affiliates or ceases to perform the function in connection with which he or she was appointed Attorney-in-fact prior to March 1, 2022, this Power of Attorney shall cease to have effect in relation to such Attorney-in- fact upon such cessation but shall continue in full force and effect in relation to the remaining Attorneys-in-fact. The Company has the unrestricted right unilaterally to revoke the Power of Attorney. This Power of Attorney shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to rules of conflicts of law. This Power of Attorney supersedes the Power of Attorney granted by the Company to Eddie Arhagba, Stephanie Snyder, Abdul Khayum, Terry Mosher, Rachel Fraizer, Apoorva Iyer, and Jerry Li on August 2, 2019. IN WITNESS WHEREOF, the undersigned has duly subscribed these presents as of December 16, 2020. GOLDMAN SACHS & CO.LLC By: /s/ Karen P. Seymour ____________________________ Name: Karen P. Seymour Title: Authorized Signatory, Managing Director Page 10 of 11 EXHIBIT (99.4) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS that GOLDMAN SACHS & CO. LLC (the "Company") does hereby make, constitute and appoint each of Stephanie Snyder, Jerry Li, Nicole Clark, Jamie Minieri, Terry Mosher, Rachel Fraizer, and Terrance Grey acting individually, its true and lawful attorney,to execute and deliver in its name and on its behalf, whether the Company is acting individually or as representative of others, any and all filings required to be made by the Company pursuant to Rule 13f-1 or Regulation 13D-G under the Securities Exchange Act of 1934, (as amended, the "Act"), which may be required of the Company with respect to securities which may be deemed to be beneficially owned by the Company under the Act, giving and granting unto each said Attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said Attorney-in-fact shall lawfully do or cause to be done by virtue hereof. THIS POWER OF ATTORNEY shall remain in full force and effect until December 1, 2021 unless earlier revoked by written instrument, or in the event an Attorney-in-fact ceases to be an employee of The Goldman Sachs Group, Inc. or one of its affiliates or ceases to perform the function in connection with which he or she was appointed Attorney-in-fact prior to December 1, 2021, this Power of Attorney shall cease to have effect in relation to such Attorney-in- fact upon such cessation but shall continue in full force and effect in relation to the remaining Attorneys-in-fact. The Company has the unrestricted right unilaterally to revoke the Power of Attorney. This Power of Attorney shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to rules of conflicts of law. This Power of Attorney supersedes the Power of Attorney granted by the Company to Stephanie Snyder, Jerry Li, Eddie Arhagba, Abdul Khayum, Terry Mosher, Rachel Fraizer, and Apoorva Iyer on August 2, 2019. IN WITNESS WHEREOF, the undersigned has duly subscribed these presents as of December 16, 2020. GOLDMAN SACHS & CO. LLC By: /s/ Karen P. Seymour ____________________________ Name: Karen P. Seymour Title: Executive Vice President and General Counsel and Secretary of the Corporation Page 11 of 11
    Get the next $TVTY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TVTY

    DatePrice TargetRatingAnalyst
    4/1/2022$31.00Neutral
    Credit Suisse
    3/11/2022$29.00 → $31.00Neutral
    Credit Suisse
    1/7/2022$25.00 → $29.00Underperform → Neutral
    Credit Suisse
    11/9/2021$21.00 → $25.00Underperform
    Credit Suisse
    More analyst ratings

    $TVTY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Credit Suisse resumed coverage on Tivity Health with a new price target

      Credit Suisse resumed coverage of Tivity Health with a rating of Neutral and set a new price target of $31.00

      4/1/22 7:17:51 AM ET
      $TVTY
      Medical Specialities
      Health Care
    • Credit Suisse reiterated coverage on Tivity Health with a new price target

      Credit Suisse reiterated coverage of Tivity Health with a rating of Neutral and set a new price target of $31.00 from $29.00 previously

      3/11/22 7:48:48 AM ET
      $TVTY
      Medical Specialities
      Health Care
    • Tivity Health upgraded by Credit Suisse with a new price target

      Credit Suisse upgraded Tivity Health from Underperform to Neutral and set a new price target of $29.00 from $25.00 previously

      1/7/22 8:22:18 AM ET
      $TVTY
      Medical Specialities
      Health Care

    $TVTY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Fortrea to Add Erin L. Russell to Board of Directors

      DURHAM, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization (CRO), today announced that it will appoint Erin L. Russell, a financial and healthcare executive, as a new independent member of the Company's Board of Directors (the "Board") effective immediately prior to the next regularly scheduled meeting of the Board. Ms. Russell is being appointed in connection with a cooperation agreement (the "Agreement") between Fortrea and Starboard Value LP (together with its affiliates, "Starboard"), an investment firm that owns approximately 5.4% of the Company's outstanding common stock. "We are pleased to have reached a constructive agree

      2/21/25 3:33:10 PM ET
      $EHTH
      $FTRE
      $KAI
      $MODV
      Specialty Insurers
      Finance
      Medical Specialities
      Health Care
    • Modivcare Announces Changes to Board of Directors

      Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Erin L. Russell has been appointed to its board of directors (the "Board"), effective February 10, 2025. Ms. Russell brings more than 25 years of experience in the healthcare and financial sectors, with a distinguished track record in capital and credit markets. On the Board, Ms. Russell will be a member of the Audit and Nominating and Govern

      2/14/25 6:00:00 AM ET
      $EHTH
      $KAI
      $MODV
      $TVTY
      Specialty Insurers
      Finance
      Industrial Machinery/Components
      Industrials
    • SilverSneakers to Offer World Class Fitness Experience from Apple Fitness+ in 2023

      Members in participating health plans will have access to workouts and meditations for all skill levels, interests, and goals with an Apple Fitness+ subscription at no additional cost NASHVILLE, Tenn., Oct. 20, 2022 /PRNewswire/ -- SilverSneakers® by Tivity Health®, the nation's leading fitness program for older adults, will offer members an Apple Fitness+™ subscription at no additional cost starting in 2023. With a Fitness+ subscription SilverSneakers members in participating health plans will have access to over 3,000 workouts and meditations including programs to get started or go after a goal and engaging audio experiences like Time to Walk and Time to Run to motivate users to get moving

      10/20/22 10:30:00 AM ET
      $TVTY
      Medical Specialities
      Health Care

    $TVTY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Wagers Ryan returned $956,150 worth of shares to the company (29,420 units at $32.50), closing all direct ownership in the company (tax withholding)

      4 - TIVITY HEALTH, INC. (0000704415) (Issuer)

      6/29/22 5:19:52 PM ET
      $TVTY
      Medical Specialities
      Health Care
    • SEC Form 4: Bilbao Joseph Raymond returned $961,708 worth of shares to the company (29,591 units at $32.50), closing all direct ownership in the company to cover withholding tax

      4 - TIVITY HEALTH, INC. (0000704415) (Issuer)

      6/29/22 5:17:41 PM ET
      $TVTY
      Medical Specialities
      Health Care
    • SEC Form 4: Lewis Thomas E returned $2,095,502 worth of shares to the company (64,477 units at $32.50), closing all direct ownership in the company to satisfy withholding obligation

      4 - TIVITY HEALTH, INC. (0000704415) (Issuer)

      6/29/22 5:15:06 PM ET
      $TVTY
      Medical Specialities
      Health Care

    $TVTY
    SEC Filings

    See more
    • SEC Form 15-12G filed by Tivity Health Inc.

      15-12G - TIVITY HEALTH, INC. (0000704415) (Filer)

      7/8/22 4:44:04 PM ET
      $TVTY
      Medical Specialities
      Health Care
    • Tivity Health Inc. filed SEC Form 8-K: Leadership Update

      8-K - TIVITY HEALTH, INC. (0000704415) (Filer)

      7/8/22 4:30:39 PM ET
      $TVTY
      Medical Specialities
      Health Care
    • SEC Form S-8 POS filed by Tivity Health Inc.

      S-8 POS - TIVITY HEALTH, INC. (0000704415) (Filer)

      6/28/22 5:29:15 PM ET
      $TVTY
      Medical Specialities
      Health Care

    $TVTY
    Leadership Updates

    Live Leadership Updates

    See more
    • Modivcare Announces Changes to Board of Directors

      Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Erin L. Russell has been appointed to its board of directors (the "Board"), effective February 10, 2025. Ms. Russell brings more than 25 years of experience in the healthcare and financial sectors, with a distinguished track record in capital and credit markets. On the Board, Ms. Russell will be a member of the Audit and Nominating and Govern

      2/14/25 6:00:00 AM ET
      $EHTH
      $KAI
      $MODV
      $TVTY
      Specialty Insurers
      Finance
      Industrial Machinery/Components
      Industrials
    • Tivity Health Appoints Stephanie Davis Michelman to Board of Directors

      NASHVILLE, Tenn., Jan. 24, 2022 /PRNewswire/ -- Tivity Health, Inc. (NASDAQ:TVTY), a leading provider of health improvement solutions, announced today the appointment of Stephanie Davis Michelman as an independent director to its Board of Directors. Michelman, most recently Vice President/General Manager, of Bobbi Brown Cosmetics (Estée Lauder Companies), has over 15 years' experience driving growth and profitability in public and private companies, working to expand several of the most well-known consumer brands. "Stephanie brings a keen insight and a wealth of experience to

      1/24/22 8:31:00 AM ET
      $TVTY
      Medical Specialities
      Health Care
    • Tivity Health Delivers Strong Results For First Quarter 2021 With 141% Year Over Year Increase In Income From Continuing Operations

      NASHVILLE, Tenn., May 5, 2021 /PRNewswire/ -- Tivity Health, Inc. (NASDAQ:TVTY), today announced financial results for the first quarter ended March 31, 2021. Richard Ashworth, President and Chief Executive Officer, commented, "We delivered strong results for the first quarter of 2021, allowing us to tighten the ranges on revenue and Adjusted EBITDA guidance for the full year. We successfully expanded our SilverSneakers virtual offerings by launching a new Roku application for viewing on-demand content and are on track to deploy our omni-channel capabilities by the start of the third quarter.  These strategic initiatives combined with the continued momentum in the number of in-person visits

      5/5/21 4:05:00 PM ET
      $TVTY
      Medical Specialities
      Health Care

    $TVTY
    Financials

    Live finance-specific insights

    See more
    • Tivity Health to Issue First Quarter 2022 Financial Results After Market Close on May 5

      NASHVILLE, Tenn., April 22, 2022 /PRNewswire/ -- Tivity Health, Inc. (NASDAQ:TVTY) (the "Company") today announced that its financial results for the first quarter ending March 31, 2022, will be released after market close on Thursday, May 5, 2022. On April 5, 2022, the Company entered into a definitive agreement to be acquired by Stone Point Capital. In light of this pending transaction, the Company will not be hosting an earnings conference call to discuss its results for the quarter and will not be providing or updating previously issued financial guidance. About Tivity Hea

      4/22/22 7:00:00 AM ET
      $TVTY
      Medical Specialities
      Health Care
    • Tivity Health Announces Definitive Agreement to Be Acquired by Stone Point Capital for $32.50 Per Share in Cash

      Total Transaction Value of $2.0 Billion NASHVILLE, Tenn., April 5, 2022 /PRNewswire/ -- Tivity Health® (NASDAQ:TVTY), a leading provider of healthy life-changing solutions, including SilverSneakers®, Prime® Fitness and WholeHealth Living®, today announced that it has entered into a definitive agreement to be acquired by funds managed by Stone Point Capital. Under the terms of the agreement, Tivity Health stockholders will receive $32.50 in cash per share, representing a total transaction value of $2.0 billion. Upon completion of the transaction, Tivity Health will become a privately held company, and its common stock will no longer be traded on Nasdaq. Anthony Sanfilippo, Chairman of the Boa

      4/5/22 8:53:00 AM ET
      $TVTY
      Medical Specialities
      Health Care
    • TIVITY HEALTH DELIVERS STRONG FOURTH QUARTER AND FULL YEAR 2021 RESULTS

      NASHVILLE, Tenn., Feb. 24, 2022 /PRNewswire/ -- Tivity Health, Inc. (NASDAQ:TVTY) (the "Company"), a leading provider of healthy life-changing solutions, including SilverSneakers®, today announced financial results for the fourth quarter and year ended December 31, 2021. Richard Ashworth, President and Chief Executive Officer, commented, "We are pleased with our financial and operational performance in 2021 supported by strength in both in-person visits and our virtual fitness offerings.  Our new mental enrichment and social connection programs for SilverSneakers members are further evidence of our ability to deliver on our strategic roadmap to offer members additional, more personalized pa

      2/24/22 4:05:00 PM ET
      $TVTY
      Medical Specialities
      Health Care

    $TVTY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Tivity Health Inc. (Amendment)

      SC 13G/A - TIVITY HEALTH, INC. (0000704415) (Subject)

      5/10/22 3:49:28 PM ET
      $TVTY
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Tivity Health Inc. (Amendment)

      SC 13G/A - TIVITY HEALTH, INC. (0000704415) (Subject)

      2/14/22 3:44:05 PM ET
      $TVTY
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Tivity Health Inc.

      SC 13G - TIVITY HEALTH, INC. (0000704415) (Subject)

      2/11/22 1:20:30 PM ET
      $TVTY
      Medical Specialities
      Health Care